)
Visual
test
Omnicell
Omnicell (OMCL) investor relations material
Omnicell Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary5 Feb, 2026
Executive summary
Achieved strong Q4 and FY 2025 results, with total revenues of $314M for Q4 (up 2% YoY) and $1.185B for the year (up 7% YoY), both above the midpoint of guidance.
Launched Titan XT, a next-generation automated dispensing system, and expanded the OmniSphere cloud platform, targeting enhanced medication management and automation.
Focused on expanding market presence, scaling recurring revenue, and accelerating technology innovation, with SaaS and Expert Services projected to comprise 22% of 2026 revenue.
Robust demand from major health systems, government facilities, and competitive wins across the U.S. and Canada.
Recognized as a Top 50 Healthcare Technology Company and for ESG performance.
Financial highlights
Q4 2025 total revenue: $314M, up 2% YoY; FY 2025 total revenue: $1.185B, up 7% YoY.
Q4 2025 non-GAAP gross margin: 43.2% (down from 47.4% YoY); Q4 non-GAAP EBITDA: $37M (11.7% margin).
Q4 2025 GAAP EPS: -$0.05; non-GAAP EPS: $0.40; FY 2025 GAAP EPS: $0.04; non-GAAP EPS: $1.62.
FY 2025 recurring revenue represented 52% of total revenue; ARR at year-end: $636M, up 10% YoY.
Year-end cash and equivalents: $197M; free cash flow Q4: $18M; product backlog: $640M.
Outlook and guidance
FY 2026 revenue guidance: $1.215B–$1.255B; product bookings: $510M–$560M; ARR: $680M–$700M.
FY 2026 non-GAAP EBITDA: $145M–$160M; non-GAAP EPS: $1.65–$1.85; SaaS and Expert Services revenue: $265M–$275M.
Q1 2026 revenue guidance: $300M–$310M; non-GAAP EBITDA: $27M–$33M; non-GAAP EPS: $0.26–$0.36.
Guidance includes $15M in tariff costs and a 13% effective tax rate.
Titan XT expected to ship in H2 2026; OmniSphere software enhancements available H1 2027.
Titan XT bookings ramp-up timeline
Drivers of GAAP net income decline in 2025
ARR growth drivers beyond new product sales
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Omnicell earnings date
Q1 20265 May, 2026
Omnicell
Next Omnicell earnings date
Q1 20265 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Omnicell Inc provides medication management automation and software solutions for healthcare providers. The company’s offerings include automated dispensing systems, robotics, and pharmacy inventory management platforms used in hospitals and pharmacies. The company is headquartered in Fort Worth, Texas, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage